Charles River Laboratories | CRL - 销售成本

股票价格
173.80
每天变化
-1.75 -1.00%
每月一次
2.90%
每年
74.24%
Q2 预测
168.66


金融业
股票价格
USD
资产
USD 7.14B
现金及等价物
USD 213.77M
销售成本
USD 722.27M
流动资产
USD 1.45B
流动负债
USD 1.12B
债务
USD 2.63B
EBIT
USD 75.82M
EBITDA
USD 258.06M
员工
18.6K
EPS每股收益
USD 2.39
股本和储备
USD 3.16B
销售毛利
USD 271.96M
债务利息支出
USD 23.78M
利息收入
USD 1.1
贷款资金
USD 2.14B
市值
USD 8.95B
净收入
USD -276.56M
营业费用
USD 918.41M
营业利润
USD 75.82M
普通股股本
USD 49.22M
PE价格收益
43.58
税前利润
USD 170.03M
销售收入
USD 994.2M
销售和管理费用
USD 196.14M
股票
USD 299.1M
贸易债权人
USD 148.8M
应收帐款人
USD 1.43B


销售成本 更改 日
Agilent USD 852M 19M 2025-12
Align Technology USD 363.97M 7.48M 2025-12
Bio-Rad Laboratories USD 309.6M 3.3M 2025-09
Bruker USD 528M 46.9M 2025-12
Cardinal Health USD 63.36B 1.57B 2025-12
Charles River Laboratories USD 722.27M 28.81M 2025-12
Cigna USD 63.37B 1.93B 2025-09
Concord Medical Services Hldg CNY 204.9M 117.04M 2025-06
CVS Health USD 92.13B 3.06B 2025-12
Danaher USD 2.87B 342M 2025-12
Dentsply International USD 518M 55M 2025-12
Elevance Health USD 38.07B 75M 2025-12
Galapagos EUR 455K 84.28M 2025-12
Hologic USD 463.7M 5.1M 2025-12
Humana USD 26.54B 1.15B 2025-03
Illumina USD 400M 49M 2025-12
Incyte USD 121.18M 22.18M 2025-12
Intrexon USD 1.01M 344K 2024-06
IQVIA Holdings USD 3.24B 518M 2025-12
Laboratory Of America USD 2.6B 56.8M 2025-12
Lonza CHF 2.28B 189M 2025-06
McKesson USD 102.47B 2.86B 2025-12
Merck EUR 2.29B 183M 2025-12
Mettler Toledo International USD 473.97M 33.71M 2025-12
Novartis USD 3.54B 3M 2025-12
Pfizer USD 6.29B 2.12B 2025-12
Quest Diagnostics USD 1.93B 27M 2025-12
Revvity USD 350.4M 26.05M 2025-12
Thermo Fisher Scientific USD 7.58B 674M 2025-12
United Therapeutics USD 474.7M 373.8M 2025-12
UnitedHealth USD 92.52B 920M 2025-09
Veradigm USD 124.74M 56.25M 2022-12
Waters USD 374.94M 47.13M 2025-12
West Pharmaceutical Services USD 501.1M 9.2M 2025-12